RxDoctor Payments DataLook up a doctor →

Suelane Ouro, MD

Interventional Pain Medicine · New York, NYNPI 1114908845

Payments from drug & device makers

$68,380in general payments, 2019–2025

Across 1,237 payments — averaging $55.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$33K
  • Boston Scientific$10K
  • MML US, Inc.$5K
  • Amgen$2K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$2K
  • Merz North America, Inc.$2K
  • plus $14K from 53 others
$820in research payments, 2019–2025

Across 1 payment — averaging $820.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$820

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic(2 entities)340$32,887
Boston Scientific123$9,955
MML US, Inc.42$4,518
Amgen(2 entities)99$2,358
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC154$2,284
Merz North America, Inc.14$2,055
Nevro Corp.28$1,906
Flowonix Medical Incorporated1$1,713
Collegium Pharmaceutical, Inc.83$1,441
AbbVie(2 entities)60$1,435
Pfizer34$701
Abbott11$641
Supernus Pharmaceuticals, Inc.22$457
Tersera Therapeutics LLC20$415
Neuronetics, Inc.2$414
Saluda Medical Americas, Inc.4$386
Scilex Pharmaceuticals Inc.22$383
Vertiflex, Inc.4$373
Relievant Medsystems, Inc.3$366
Si-bone, Inc.7$352
Galderma Laboratories, L.p.17$330
Protega Pharmaceutials Inc12$327
Forte Bio-pharma LLC16$283
Daiichi Sankyo Inc.19$250
Kowa Pharmaceuticals America, Inc.10$245
Zyla Life Sciences, Inc.18$236
Novartis6$154
Assertio Therapeutics, Inc.6$135
SPR Therapeutics, Inc1$118
Almatica Pharma LLC5$100
Fidia Pharma USA Inc.5$96
GRT US Holding, Inc.4$92
Redhill Biopharma Inc.5$90
Painteq LLC1$89
Hikma Pharmaceuticals USA4$68
Nalu Medical, Inc.2$62
Biohaven Pharmaceutical Holding Company Ltd.3$61
Johnson & Johnson3$49
Biohaven Pharmaceuticals, Inc.2$47
Takeda Pharmaceuticals U.S.A., Inc.2$43
Tonix Medicines, Inc.1$40
Biodelivery Sciences International, Inc.2$38
Amneal Pharmaceuticals LLC2$37
MDD US Operations, LLC1$32
Shionogi Inc2$28
AstraZeneca2$25
GE HealthCare1$25
Bioventus LLC1$24
Merz Pharmaceuticals, LLC1$23
Piramal Critical Care1$23
Indivior Inc.1$21
Vertos Medical, Inc.1$21
Pernix Therapeutics Holdings, Inc.1$20
Valinor Pharma, LLC1$19
Azurity Pharmaceuticals, Inc.1$19
Teva Pharmaceuticals USA, Inc.1$19
Medline Industries LP1$18
Otsuka America Pharmaceutical, Inc.1$18
IBSA Pharma Inc.1$17

How this compares

$68,380 in reported general payments places this provider in the 90th percentile of 132 interventional pain medicine providers in New York.

See all interventional pain medicine providers in New York →

Medicare billing

Part B allowed, 2024
$971,647
Medicare patients
315
Services billed
22,698

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional pain medicine in New York

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →